The prevalence of antithrombin (AT) deficiency in 342 unselected Brazilian patients with venous thrombosis was 1.16%, which increased to 3% when only patients under the age of 50 or with a familial history of thrombosis were considered. In two patients, a clinical (contraceptive use) or genetic risk factor (factor V Leiden and C677T in the methylene tetrahydrofolate reductase gene [MTHFR]) was identified and corroborated the hypothesis that an interaction of factors accounted for the appearance of thrombosis. However, no risk factor other than AT deficiency was identified in one patient with an important clinical and family history of spontaneous thrombosis. Three mutations were identified in these patients: a G → A transition in intron 5 at position +1 (5′ → 3′), three base insertions corresponding to arginine at position 5383 in exon 3A, and a G → A transition at 13328, corresponding to an Ala404Thr de novo mutation. The polymorphisms in the genes coding for coagulation factors XII and XIII and fibrinogen normally associated with an increased risk for venous thrombosis were not related to thrombosis in these patients. This is the first study in South America to assess the prevalence of AT deficiency and to report the molecular characterization of the mutations involved. © 2001 Elsevier Science Ltd. All rights reserved.1046397403Cooper, D.N., Krawczak, M., (1997) Antithrombin III and antithrombin III deficiency. Venous thrombosis: from genes to clinical medicine, pp. 37-59. , Oxford: BIOS Scientific PublishersLane, D.A., Bayston, T.A., Molecular basis of antithrombin action and deficiency (1977) Landes Bioscience, 7, pp. 39-77. , Schafer AI, editor. Medical intelligence unit. Molecular mechanisms of hypercoagulable statesRao, L.V.M., Rappaport, S.I., Hoang, A.D., Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa (1993) Blood, 81, pp. 2600-2607Jochmans, K., Lissens, W., Vervoort, R., Peeters, S., Waele, M.D., Liebaers, I., Antithrombin-Gly 424 Arg: A novel point mutation responsible for type I antithrombin deficiency and neonatal thrombosis (1994) Blood, 83, pp. 146-151Nakahara, Y., Tsuji, H., Nakagawa, K., Masuda, H., Kitamura, H., Nishimura, H., Kasahara, T., Nakagawa, M., Genetic analysis in Japanese kindreds of congenital type I antithrombin deficiency causing thrombosis (1997) Thromb Haemostasis, 77, pp. 616-619Olds, R.J., Lane, D.A., Chowdhury, V., De Stefano, V., Leone, G., Thein, S.I., Complete nucleotide sequence of the antithrombin gene: Evidence for homologous recombination causing thrombophilia (1993) Biochemistry, 32, pp. 4216-4224Blajchman, M.A., Austin, R.C., Fernandez-Rachubinski, F., Sheffield, W.P., Molecular basis of inherited human antithrombin deficiency (1992) Blood, 80, pp. 2159-2171Vidaud, D., Emmerich, J., Sirieix, M.E., Sié, P., Alhenc-Gelas, M., Aiach, M., Molecular basis for antithrombin III type I deficiency: Three novel mutations located in exon IV (1991) Blood, 78, pp. 2305-2309Iolascon, A., Parella, T., Perota, S., Guardamagna, O., Coates, P.M., Sartore, M., Surrey, S., Fortina, P., Rapid detection of medium chain Acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels (1994) J Med Genet, 31, pp. 551-554Ganguly, A., Rock, M.J., Prockop, D.J., Conformation-sensitive gel electrophoresis for detection of single-base differences in double-strand PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes (1993) Proc Natl Acad Sci USA, 90, pp. 10325-10329Sanger, F., Niklens, S., Coulson, A.R., DNA sequencing with chain terminating inhibitors (1977) Proc Natl Acad Sci USA, 74, pp. 5463-5467Seixas, C.A., Hessel, G., Ribeiro, C.C., Arruda, V.R., Annichino-Bizzacchi, J.M., Factor V Leiden is not common in children with portal vein thrombosis (1997) Thromb Haemostasis, 77, pp. 258-261Torresan, M., Machado, T.F.G.S., Siqueira, L.H., Ozelo, M.C., Arruda, V.R., Annichino-Bizzacchi, J.M., The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis (2000) Blood Coagulation Fibrinolysis, 11, pp. 1-4Kohler, H.P., Fusters, T.S., Grant, P.J., Factor XII (46C → T) polymorphism and in vivo generation of factor XII activity, gene frequencies and relationship in coronary artery disease (1999) Thromb Haemostasis, 81, pp. 745-747Barbosa, H.C.L., Mansur, A.P., Siqueira, L.H., Chiaparini, L.C., Arruda, V.R., Annichino-Bizzacchi, J.M., The protective effect of factor XIII Val34Leu on the risk of myocardial infarction (2000) Haemostasis, 30, p. 44Thomas, A.E., Green, F.R., Kelleher, C.H., Brennan, P.J., Meade, T.W., Humphries, S.E., Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers (1991) Thromb Haemostasis, 65, pp. 487-490Rosendaal, F., Risk factors for venous thrombosis: Prevalence, risk and interaction (1997) Semin Hematol, 3, pp. 171-187Simioni, P., Bernd-Jan, S., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Prins, M., Incidence of venous thromboembolism in families with inherited thrombophilia (1999) Thromb Haemostasis, 81, pp. 198-202Singh, Y.S., Arruda, V.R., Ozello, M.C., Machado, T.F.G.S., Annichino-Bizzacchi, J.M., Identification of one novel and three other point mutations in the protein C gene of five unrelated Brazilian patients with hereditary protein C deficiency (2000) Haematologica, 85, pp. 891-893Csurgay, E., Ireland, H., Thompson, E., Conard, J., Manucci, P.M., Andrews, V., Worsley, A., Lane, D.A., Novel mutations in seven families with type I antithrombin deficiency (1995) Thromb Haemostasis, 73, p. 935Arnaldi, L.A.T., Polimeno, N.C., Arruda, V.R., Annichino-Bizzacchi, J.M., A novel splice site mutation in a Brazilian patient with hereditary antithrombin deficiency type I (1999) Hum Hered, 49, pp. 119-120Lane, D.A., Bayston, T., Olds, R.J., Fitches, A.C., Cooper, D.N., Millar, D.S., Jochmans, K., Emmerich, J., Antithrombin mutation database: 2nd (1997) update (1997) Thromb Haemostasis, 77, pp. 197-211Lane, D.A., Olds, R.J., Conard, J., Boisclair, M., Bock, S.C., Hultin, M., Abildgaard, U., Thein, S.L., Pleiotropic effects of antithrombin strand 1C substitution mutations (1992) J Clin Invest, 90, pp. 2422-2433Rosetto, A., Rodeguiero, F., Martinelli, I., De Stefano, V., Missiaglia, E., Chiusolo, P., Mannucci, P.M., Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation (1998) Br J Haematol, 103, pp. 871-876McColl, M., Tait, R.C., Walker, I.D., Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: Correlation with type of defect, family history and absence of the factor V Leiden mutation (1996) Blood Coagulation Fibrinolysis, 7, pp. 689-694